D-dimer in Pediatric Population
D-dimer testing has not been formally validated in children, and pediatric reference ranges are significantly higher than adult values, requiring age-specific interpretation when used clinically 1.
Key Limitations in Pediatric Use
The most authoritative guideline explicitly states that D-dimers have not been formally evaluated in children; therefore, the pretest likelihood of confirmed thrombosis is unknown 1. This fundamental limitation means that adult cutoffs and interpretation strategies cannot be directly applied to pediatric patients.
Age-Specific Reference Ranges
Neonatal Period (0-28 days)
- Mean D-dimer: 1.74 ± 1.88 mg/L (reference range: 0.25-2.81 mg/L) 2
- Values are highest in the first week (2.44-2.45 mg/L) and gradually decrease but remain above adult levels throughout the first month
- D-dimer inversely correlates with postnatal age (r: -0.3, p<0.001)
- No significant gender differences exist
Children and Adolescents
Pediatric D-dimer levels remain elevated compared to adult standards due to developmental hemostasis—the physiological differences in coagulation proteins and inhibitors that persist through childhood and normalize at puberty 1.
Clinical Applications Where D-dimer May Be Useful
Pulmonary Embolism Evaluation (Most Studied)
In adolescents with suspected PE, a D-dimer threshold of ≥750 ng/mL provides better discriminative value than the adult cutoff of 500 ng/mL 3. The evidence shows:
- At 500 ng/mL cutoff: 90% sensitivity, 16% specificity
- At 750 ng/mL cutoff: 82% sensitivity, 53% specificity
- At 1000 ng/mL cutoff: 67% sensitivity, 67% specificity
For children aged 5-17 years with low clinical probability of PE, a normal D-dimer (≤500 ng/mL) can safely exclude PE with 100% sensitivity (95% CI: 89-100%) 4. However, this was predominantly studied in teenagers (88% of tests ordered in children >12 years).
Head Trauma
D-dimer ≤0.5 μg/mL has 100% sensitivity and negative predictive value for excluding intracranial injury or skull fracture in children with head trauma 5. This holds across age groups (<2 years and ≥2 years), making it potentially useful to limit CT exposure.
Musculoskeletal Infections
D-dimer >0.43 mg/L shows 95.2% sensitivity and 81.8% specificity for pediatric musculoskeletal infections, though it ranks below CRP and ESR in diagnostic accuracy 6.
Critical Caveats
Clinical prediction models and D-dimer measurement require further prospective pediatric-specific validation before routine implementation 7. The pretest probability tools validated in adults have not been adequately studied in children.
Common Pitfalls to Avoid:
- Do not use adult reference ranges in neonates or young children—values will appear falsely elevated
- Do not order D-dimer without clinical probability assessment—the positive predictive value is poor even in adolescents
- Do not use D-dimer for screening asymptomatic children—it lacks validation for this purpose
- Ensure peripheral venous sampling—central line samples may be contaminated with heparin, causing artificially prolonged results 1
Practical Algorithm for Use
When considering D-dimer in pediatrics:
- Confirm the clinical indication is appropriate (suspected PE in adolescents, head trauma evaluation, or as part of research protocols)
- Assess clinical pretest probability using validated tools when available
- Use age-appropriate reference ranges:
- Neonates: 0.25-2.81 mg/L
- Adolescents with suspected PE: Consider 750 ng/mL threshold
- Head trauma: 0.5 μg/mL cutoff
- Interpret negative results to exclude disease (high sensitivity), but recognize positive results require imaging confirmation (poor specificity)
- Consult hematology experts when results are abnormal or interpretation is unclear 1
The primary evidence-based role for D-dimer in pediatrics is to safely exclude PE in adolescents with low clinical probability and to reduce unnecessary CT imaging in head trauma patients, not as a screening or diagnostic confirmation tool 7, 4.